Watch back our webinar on patient preferences for lung cancer treatment!

21-9

Bildtext

One of PREFER’s core case studies explored patient preferences for lung cancer treatments, assessing which trade-offs between benefit and risks related to treatment alternatives that patients are willing to accept or not. In the recording from our 13 January webinar, we describe the design of the study, its main results, and lesson learnt in conducting the preference study with this vulnerable population of patients.

The recoded webinar is now available on the PREFER YouTube channelYou can watch it in its entirety or scroll to find the parts below. If you want to be invited to future PREFER webinars, sign up for our newsletter! Or have a look at our event calendar to find out what has been planned already.

Future PREFER events (Link removed)  

PREFER, patient preferences & the lung cancer case study - Isabelle Huys & Serena Oliveri

YouTube

Patient preferences for non-small-cell lung cancer treatment: A qualitative study - Rosanne Janssens

YouTube

Use of educational tools: Experience from the PREFER lung cancer case study - Meredith Smith

YouTube

Patient preferences for non-small-cell lung cancer treatment: A quantitative study - Serena Oliveri

YouTube

CONTACT US

X: @IMI_PREFER

LinkedIn

YouTube

  •  
  • Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.
  •  

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).